Chief Executive Officer

Chief Financial Officer

Hemab Therapeutics Announces Positive Complete Phase 2 Data for Sutacimig in Glanzmann Thrombasthenia at ASH 2025; Plans to Advance to Pivotal Phase 3 Study

Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs

Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders

Hemab Therapeutics Appoints Anant Murthy, PhD, as Chief Operating Officer

Director Biostatistics

Hemab Therapeutics is a clinical-stage biotech company focused on addressing the high unmet needs of patients suffering from rare bleeding and thrombotic disorders. The Director of Biostatistics will develop statistical strategies for clinical programs, providing leadership and expertise to guide innovative therapies through regulatory approval.

Director Biostatistics ar Hemab

0.25 Director/Senior Director of Clinical Research

Hemab Therapeutics is a clinical-stage biotech company focused on developing innovative treatments for rare bleeding and thrombotic disorders. The Director/Senior Director of Clinical Research will lead clinical development strategies and manage studies across Phase 1-3 programs, ensuring alignment with corporate objectives while collaborating with various teams.

Director Biostatistics Ar Hemab

Director Biostatistics Ar Hemab in united states (1000+)

Director Biostatistics ar Hemab

Director/Senior Director of Clinical Research